Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Asset Utilization Ratio: 2013-2025

Historic Asset Utilization Ratio for Enanta Pharmaceuticals (ENTA) over the last 13 years, with Sep 2025 value amounting to 0.22.

  • Enanta Pharmaceuticals' Asset Utilization Ratio rose 28.74% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year increase of 28.74%. This contributed to the annual value of 0.20 for FY2025, which is 23.26% up from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Asset Utilization Ratio of 0.22 as of Q3 2025, which was up 8.12% from 0.21 recorded in Q2 2025.
  • Over the past 5 years, Enanta Pharmaceuticals' Asset Utilization Ratio peaked at 0.24 during Q1 2023, and registered a low of 0.17 during Q4 2023.
  • In the last 3 years, Enanta Pharmaceuticals' Asset Utilization Ratio had a median value of 0.18 in 2024 and averaged 0.19.
  • Per our database at Business Quant, Enanta Pharmaceuticals' Asset Utilization Ratio plummeted by 42.19% in 2021 and then climbed by 28.74% in 2025.
  • Over the past 5 years, Enanta Pharmaceuticals' Asset Utilization Ratio (Quarterly) stood at 0.21 in 2021, then grew by 7.40% to 0.23 in 2022, then declined by 27.22% to 0.17 in 2023, then rose by 11.09% to 0.18 in 2024, then increased by 28.74% to 0.22 in 2025.
  • Its Asset Utilization Ratio was 0.22 in Q3 2025, compared to 0.21 in Q2 2025 and 0.19 in Q1 2025.